Release Date: 08/08/16 09:37 Summary: Change in substantial holding from IFL,IFL-TGA.AX Price Sensitive: No Download Document 43.16KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%